Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.James Sidoti is an analyst at Sidoti & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
05/29/2024 | SRDX | Buy Now | Surmodics | $27.67 | 55.4% | James Sidoti65% | → $43 | Downgrade | Buy → Neutral | Get Alert |
11/07/2022 | STAA | Buy Now | Staar Surgical | $18.25 | — | James Sidoti65% | — | Upgrade | Neutral → Buy | Get Alert |
08/12/2022 | CODX | Buy Now | Co-Diagnostics | $0.35 | 1328.16% | James Sidoti65% | → $5 | Downgrade | Buy → Neutral | Get Alert |
08/31/2020 | STAA | Buy Now | Staar Surgical | $18.25 | 217.81% | James Sidoti65% | → $58 | Upgrade | Neutral → Buy | Get Alert |
04/08/2020 | LMAT | Buy Now | LeMaitre Vascular | $90.91 | -62.6% | James Sidoti65% | $38 → $34 | Maintains | Buy | Get Alert |
03/27/2020 | HSKA | Buy Now | Heska | — | — | James Sidoti65% | $77 → $59 | Maintains | Neutral | Get Alert |
03/16/2020 | LMAT | Buy Now | LeMaitre Vascular | $90.91 | -58.2% | James Sidoti65% | → $38 | Upgrade | Neutral → Buy | Get Alert |
01/21/2020 | ANIK | Buy Now | Anika Therapeutics | $14.00 | 335.71% | James Sidoti65% | → $61 | Upgrade | Neutral → Buy | Get Alert |
01/15/2020 | HSKA | Buy Now | Heska | — | — | James Sidoti65% | $72 → $77 | Maintains | Neutral | Get Alert |
02/22/2019 | ANIK | Buy Now | Anika Therapeutics | $14.00 | 192.86% | James Sidoti65% | $56 → $41 | Downgrade | Buy → Neutral | Get Alert |
07/01/2016 | HSKA | Buy Now | Heska | — | — | James Sidoti65% | — | Initiates | → Buy | Get Alert |